| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.35B | 9.43B | 10.32B | 8.53B | 7.64B | 6.37B |
| Gross Profit | 8.57B | 7.66B | 8.58B | 7.03B | 6.18B | 5.21B |
| EBITDA | 3.84B | 1.73B | 3.83B | 1.90B | 1.65B | 1.50B |
| Net Income | 1.69B | 1.95B | 1.55B | 483.46M | -6.05B | 395.33M |
Balance Sheet | ||||||
| Total Assets | 37.47B | 39.55B | 38.28B | 35.19B | 31.89B | 36.54B |
| Cash, Cash Equivalents and Short-Term Investments | 25.15B | 27.08B | 26.58B | 23.86B | 21.33B | 19.09B |
| Total Debt | 32.53M | 25.26M | 3.02B | 2.84B | 2.80B | 2.45B |
| Total Liabilities | 6.28B | 6.89B | 9.87B | 8.62B | 7.73B | 7.74B |
| Stockholders Equity | 25.12B | 26.05B | 22.46B | 21.29B | 19.50B | 24.78B |
Cash Flow | ||||||
| Free Cash Flow | 3.41B | 2.26B | 4.16B | 3.01B | 2.06B | 1.92B |
| Operating Cash Flow | 3.88B | 2.57B | 4.59B | 3.49B | 2.57B | 2.22B |
| Investing Cash Flow | 181.50M | -1.18B | -8.52B | -6.48B | 4.42B | -1.61B |
| Financing Cash Flow | -1.89B | -1.89B | -1.08B | 655.86M | -619.04M | -479.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$3.55B | 7.47 | 17.91% | 3.82% | -4.19% | 0.41% | |
73 Outperform | HK$553.91B | 18.22 | 22.14% | 2.22% | 6.96% | 14.02% | |
69 Neutral | HK$30.59B | 18.73 | 44.75% | 1.18% | 14.94% | 86.33% | |
67 Neutral | HK$31.83B | 9.26 | 8.02% | 0.48% | -6.10% | 25.65% | |
66 Neutral | HK$70.08B | 35.85 | 8.04% | ― | 13.20% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
48 Neutral | HK$4.58B | 33.82 | 2.70% | 8.76% | -26.02% | -51.13% |